Arizona Health Sciences

Medicine & Life Sciences

1. Acupuncture 9%
2. acylcarnitine 7%
3. Alleles 15%
4. Antidepressive Agents 63%
5. Anxiety 16%
6. Anxiety Disorders 11%
7. Aptitude 7%
8. Biomedical Research 6%
9. Brain 13%
10. Carnitine 10%
11. Case-Control Studies 7%
12. Catecholamines 17%
13. Cerebrospinal Fluid 30%
14. Chronic Disease 6%
15. Cognitive Remediation 13%
16. Corpus Striatum 8%
17. Cross-Sectional Studies 5%
18. Depression 100%
19. Desipramine 11%
20. Diagnostic and Statistical Manual of Mental Disorders 5%
21. Electroconvulsive Therapy 7%
22. Emotions 6%
23. Equipment and Supplies 8%
24. Fluoxetine 10%
25. gamma-Aminobutyric Acid 8%
26. Genes 18%
27. Genetic Polymorphisms 9%
28. Genetic Promoter Regions 19%
29. Genotype 16%
30. Hallucinogens 20%
31. Health 5%
32. Healthy Volunteers 8%
33. Hispanic Americans 25%
34. Homovanillic Acid 6%
35. Hydroxyindoleacetic Acid 9%
36. IDS 30 9%
37. Income 7%
38. Individuality 8%
39. Internet 8%
40. Learning 7%
41. Lubrication 5%
42. Major Depressive Disorder 32%
43. Medically Unexplained Symptoms 5%
44. Mental Health 7%
45. Mentally Ill Persons 10%
46. Mirtazapine 27%
47. Mood Disorders 7%
48. Multifactorial Inheritance 10%
49. Neuroticism 10%
50. Neurotransmitter Agents 8%
51. Norepinephrine 17%
52. Observational Studies 6%
53. Obsessive-Compulsive Disorder 41%
54. Orgasm 11%
55. Penile Erection 6%
56. Pharmaceutical Preparations 7%
57. Pharmacokinetics 7%
58. Pindolol 12%
59. Placebos 6%
60. Population 8%
61. Postpartum Period 8%
62. Pregnancy 5%
63. Primary Health Care 16%
64. Prospective Studies 5%
65. Psilocybin 29%
66. Psychiatry 18%
67. Psychological Distress 8%
68. Psychological Stress 5%
69. Psychopathology 6%
70. Psychotic Disorders 8%
71. Randomized Controlled Trials 11%
72. Receptor, Serotonin, 5-HT2C 5%
73. Recurrence 9%
74. Reproducibility of Results 7%
75. Respiratory Sinus Arrhythmia 12%
76. Safety 6%
77. Serotonin 77%
78. Serotonin 5-HT2 Receptor Agonists 5%
79. Serotonin Plasma Membrane Transport Proteins 43%
80. Serotonin Uptake Inhibitors 22%
81. Sertraline 11%
82. Sex Characteristics 8%
83. Spinal Puncture 13%
84. Substance P 9%
85. Suicide 8%
86. Synaptic Transmission 8%
87. Therapeutics 18%
88. Treatment-Resistant Depressive Disorder 60%
89. Tryptophan 95%
90. Unemployment 10%
91. Vagus Nerve Stimulation 68%
92. Valproic Acid 9%